Figure 5.
Blood tumor mutational burden (bTMB) according to disease stage and histological type. There were no significant differences in the pre-treatment baseline bTMB levels among groups with different disease stage (A) and histological type (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.